Literature DB >> 12138790

Patient satisfaction with bilateral bone-anchored hearing aids: the Birmingham experience.

Sunil N Dutt1, Ann-Louise McDermott, Stuart P Burrell, Huw R Cooper, Andrew P Reid, David W Proops.   

Abstract

The Birmingham bone-anchored hearing aid (BAHA) programme has fitted more than 300 patients with unilateral bone-anchored hearing aids since 1988. Some of the patients who benefited well with unilateral aids and who had used bilateral conventional aids previously applied for bilateral amplification. To date, 15 patients have been fitted with bilateral BAHAs. The benefits of bilateral amplification have been compared to unilateral amplification in 11 of these patients. Subjective analysis in the form of validated comprehensive questionnaires was undertaken. The Glasgow benefit inventory (GBI), which is a subjective patient orientated post-interventional questionnaire developed to evaluate any otorhinolaryngological surgery and therapy was administered. The results revealed that the use of bilateral bone-anchored hearing aids significantly enhanced general well being (patient benefit) and improved the patient's state of health (quality of life). The Chung and Stephens questionnaire which addresses specific issues related to binaural hearing was used. Our preliminary results are encouraging and are comparable to the experience of the Nijmegen BAHA group.

Entities:  

Mesh:

Year:  2002        PMID: 12138790

Source DB:  PubMed          Journal:  J Laryngol Otol Suppl        ISSN: 0144-2945


  3 in total

1.  BAHA: Bone-Anchored Hearing Aid.

Authors:  Abdulrahman Hagr
Journal:  Int J Health Sci (Qassim)       Date:  2007-07

2.  The Merits of Bilateral Application of Bone-Conduction Devices in Children With Bilateral Conductive Hearing Loss.

Authors:  Chrisje A den Besten; Katharina Vogt; Arjan J Bosman; Ad F M Snik; Myrthe K S Hol; Martijn J H Agterberg
Journal:  Ear Hear       Date:  2020 Sep/Oct       Impact factor: 3.562

Review 3.  The Glasgow Benefit Inventory: a systematic review of the use and value of an otorhinolaryngological generic patient-recorded outcome measure.

Authors:  J Hendry; A Chin; I R C Swan; M A Akeroyd; G G Browning
Journal:  Clin Otolaryngol       Date:  2016-02-07       Impact factor: 2.597

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.